Infection, Bacterial Clinical Trial
Official title:
Therapeutic Drug Monitoring of Antiinfectives for Patients With Severe Illness
Therapeutic drug monitoring of antiinfectives in intensive care patients is an usual research topic of the last years. Based on research result, which have shown subtherapeutic plasma concentrations of antibiotics, a routines therapeutic drug monitoring for β-lactam-antibiotics was implemented in January 2018 at Clinic for Anesthesiology at University Hospital, LMU Munich, Germany. This study is an prospective evaluation of these TDM-program.
Bacterial infections are associated with high mortality in intensive care patients. Antibiotic therapy is the only causal opportunity to treat those infections. Pharmacokinetic and -dynamic changes in critically ill patients lead to unpredictable plasma concentrations of the applied drugs. Research results of the last years with many quantified plasma concentrations in subtherapeutic levels yield to the recommendation of the Paul-Ehrlich-Society for an routines therapeutic drug monitoring of antibiotics in intensive care patients. These was implemented in January 2018 at Clinic for Anesthesiology at University Hospital, LMU Munich, Germany for all intensive care patients as a routines procedure. The introduced study is a prospective evaluation of the TDM-program with regard to improvement opportunity, influencing factors and parallels to other studies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05846399 -
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
|
Phase 4 | |
| Recruiting |
NCT05904535 -
Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections
|
||
| Not yet recruiting |
NCT04075344 -
Effect of a Infection Control Program on the Reduction of Bacterial Contamination on NG Tube Feeding in RCHEs
|
N/A | |
| Completed |
NCT05333133 -
High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children
|
N/A | |
| Recruiting |
NCT05950984 -
Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
|
||
| Recruiting |
NCT06283433 -
A Dried Blood Spot Sampling Method for Vancomycin and Creatinine Monitoring for OPAT
|
N/A | |
| Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
| Completed |
NCT03688321 -
Probiotic on Prevention of GBS Vaginal Infection During Pregnancy
|
N/A | |
| Completed |
NCT03244917 -
Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias
|
N/A | |
| Recruiting |
NCT04450680 -
Beta-lactam Therapeutic Drug Monitoring in Singapore
|
||
| Completed |
NCT05686577 -
How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive Care
|
||
| Recruiting |
NCT06093269 -
Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)
|
Phase 4 | |
| Recruiting |
NCT05587283 -
Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women
|
Phase 1 | |
| Recruiting |
NCT03752424 -
Topical Silver Nanoparticles for Microbial Activity
|
Phase 1 | |
| Completed |
NCT04440631 -
Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
|
||
| Active, not recruiting |
NCT05150015 -
ElastoMeric Infusion Pumps for Hospital AntibioTICs
|
N/A | |
| Completed |
NCT03816956 -
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
|
Phase 3 | |
| Terminated |
NCT03555981 -
Early Kangaroo Mother Care in Gambian Hospitalised Unstable Neonates
|
N/A | |
| Completed |
NCT03133312 -
Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery
|
Phase 4 | |
| Recruiting |
NCT04800575 -
Comparison of Sterile Gauze and Semi-permeable Film Dressing for Hemodialysis Central Venous Catheter
|
N/A |